Presentation TCT 2016 Trial #6 - The Essentials of PARTNER 2 and SAPIEN 3 - TAVR In Intermediate Risk Patients, and Improved TAVR Devices Presenter: Vinod H. Thourani October 31, 2016 REGISTER for free or LOG IN to view this content Structural Heart Presentation TCT 2016 Aortic Valve Up Next Presentation TCT 2016 Controversy 1. Is Cerebral Embolic Protection Needed for TAVR? The Evidence: Observations From DEFLECT 3, CLEAN-TAVI, and the SENTINEL Clinical Trials Presenter: Samir R. Kapadia October 31, 2016 More slides + Presentation TCT 2016 Flash Debate: Point Cerebral Protection Is a Must for All Patients! Presenter: Axel Linke October 31, 2016 Presentation TCT 2016 PARTNER 2 and SAPIEN 3 Critique: Pros and Cons Presenter: Stephan Windecker October 31, 2016 We Recommend
Presentation TCT 2016 Controversy 1. Is Cerebral Embolic Protection Needed for TAVR? The Evidence: Observations From DEFLECT 3, CLEAN-TAVI, and the SENTINEL Clinical Trials Presenter: Samir R. Kapadia October 31, 2016
Presentation TCT 2016 Flash Debate: Point Cerebral Protection Is a Must for All Patients! Presenter: Axel Linke October 31, 2016
Presentation TCT 2016 PARTNER 2 and SAPIEN 3 Critique: Pros and Cons Presenter: Stephan Windecker October 31, 2016